ArticleCancers2026

A High-Fidelity Patient-Derived Organoid Platform Recapitulates the Dynamic Metabolic Landscape of Cisplatin Tolerance in Mesothelioma.

Zivile Useckaite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.